These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 9580648

  • 1. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D.
    N Engl J Med; 1998 May 14; 338(20):1413-21. PubMed ID: 9580648
    [Abstract] [Full Text] [Related]

  • 2. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF.
    Hum Pathol; 2001 Sep 14; 32(9):963-9. PubMed ID: 11567226
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.
    Oncogene; 1997 Jun 19; 14(24):2899-916. PubMed ID: 9205097
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus in action in vivo.
    Rickinson AB.
    N Engl J Med; 1998 May 14; 338(20):1461-3. PubMed ID: 9580656
    [No Abstract] [Full Text] [Related]

  • 5. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.
    Oncogene; 2004 Apr 08; 23(15):2681-93. PubMed ID: 14767477
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 08; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 7. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF.
    Oncogene; 1999 Nov 25; 18(50):7161-7. PubMed ID: 10597317
    [Abstract] [Full Text] [Related]

  • 8. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.
    J Natl Cancer Inst; 2004 Oct 06; 96(19):1447-57. PubMed ID: 15467034
    [Abstract] [Full Text] [Related]

  • 9. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H, Ishii C, Suehiro M, Iguchi A, Kuroda K, Shimizu K, Shimizu N, Imadome K, Yajima M, Fujiwara S.
    Virus Res; 2008 Feb 06; 131(2):170-9. PubMed ID: 17963943
    [Abstract] [Full Text] [Related]

  • 10. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription.
    Rothenberger S, Bachmann E, Berger C, McQuain C, Odermatt BF, Knecht H.
    Oncogene; 1997 May 01; 14(17):2123-6. PubMed ID: 9160892
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G.
    Am J Pathol; 1993 Oct 01; 143(4):1072-85. PubMed ID: 8214003
    [Abstract] [Full Text] [Related]

  • 12. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 13. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP, Aggarwal BB, Shishodia S, Estrov Z, Kurzrock R.
    Leukemia; 2003 Nov 15; 17(11):2196-201. PubMed ID: 14523478
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF.
    Rev Clin Exp Hematol; 2003 Dec 15; 7(4):362-74. PubMed ID: 15129648
    [Abstract] [Full Text] [Related]

  • 15. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W.
    Cancer Res; 2003 Jun 01; 63(11):2982-9. PubMed ID: 12782607
    [Abstract] [Full Text] [Related]

  • 16. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, Greiner TC.
    Lab Invest; 1996 Oct 01; 75(4):575-88. PubMed ID: 8874388
    [Abstract] [Full Text] [Related]

  • 17. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH, Chen CL, Li WY, Chen CJ.
    Carcinogenesis; 2009 Aug 01; 30(8):1443-51. PubMed ID: 19483191
    [Abstract] [Full Text] [Related]

  • 18. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG, Young LS.
    Oncogene; 1998 Apr 02; 16(13):1731-42. PubMed ID: 9582021
    [Abstract] [Full Text] [Related]

  • 19. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.
    J Med Virol; 2001 Sep 02; 65(1):114-20. PubMed ID: 11505452
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May 02; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.